Just as it’s putting the finishing touches on a private options offering that should net some $3 million in cash, Cambridge Heart Inc. (OTC:CAMH) is warning investors that it will need more money to stay afloat past the end of 2011. “While the proceeds from our December 2010 private placement of common stock and the […]
Cambridge Heart Inc. (OTC:CAMH) is looking to tap the micro-cap investment sector, hiring an outside firm to tout its cardiac disease testing technology. The Tewksbury, Mass.-based firm said it tapped Wolfe Axelrod Weinberger Associates as its investor relations agency, effective immediately.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!